Literature DB >> 3494734

Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells.

B M Ewenstein, M J Warhol, R I Handin, J S Pober.   

Abstract

von Willebrand factor (VWF) is a large, adhesive glycoprotein that is biosynthesized and secreted by cultured endothelial cells (EC). Although these cells constitutively release VWF, they also contain a storage pool of this protein that can be rapidly mobilized. In this study, a dense organelle fraction was isolated from cultured umbilical vein endothelial cells by centrifugation on a self-generated Percoll gradient. Stimulation of EC by 4-phorbol 12-myristate 13-acetate (PMA) resulted in the disappearance of this organelle fraction and the synchronous loss of Weibel-Palade bodies as judged by immunoelectron microscopy. Electrophoretic and serologic analyses of biosynthetically labeled dense organelle fraction revealed that it is comprised almost exclusively of VWF and its cleaved pro sequence. These two polypeptides were similarly localized exclusively to Weibel-Palade bodies by ultrastructural immunocytochemistry. The identity of the dense organelle as the Weibel-Palade body was further established by direct morphological examination of the dense organelle fraction. The VWF derived from this organelle is distributed among unusually high molecular weight multimers composed of fully processed monomeric subunits and is rapidly and quantitatively secreted in unmodified form after PMA stimulation. These studies: establish that the Weibel-Palade body is the endothelial-specific storage organelle for regulated VWF secretion; demonstrate that in cultured EC, the VWF concentrated in secretory organelles is of unusually high molecular weight and that this material may be rapidly mobilized in unmodified form; imply that proteolytic processing of VWF involved in regulated secretion takes place after translocation to the secretory organelle; provide a basis for further studies of intracellular protein trafficking in EC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494734      PMCID: PMC2114468          DOI: 10.1083/jcb.104.5.1423

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  52 in total

1.  Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

2.  Selection and characterization of bovine aortic endothelial cells.

Authors:  S M Schwartz
Journal:  In Vitro       Date:  1978-12

3.  Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

4.  Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.

Authors:  Z M Ruggeri; P M Mannucci; R Lombardi; A B Federici; T S Zimmerman
Journal:  Blood       Date:  1982-06       Impact factor: 22.113

5.  Synthesis and release of factor VIII by cultured human endothelial cells.

Authors:  E G Tuddenham; J Lazarchick; L W Hoyer
Journal:  Br J Haematol       Date:  1981-04       Impact factor: 6.998

6.  Applications of immunocolloids in light microscopy. Preparation of protein A-silver and protein A-gold complexes and their application for localization of single and multiple antigens in paraffin sections.

Authors:  J Roth
Journal:  J Histochem Cytochem       Date:  1982-07       Impact factor: 2.479

7.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.

Authors:  H J Weiss; I I Sussman; L W Hoyer
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

8.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Synthesis of von Willebrand factor by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.

Authors:  R Nachman; R Levine; E A Jaffe
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more
  43 in total

Review 1.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Protein mobilities and P-selectin storage in Weibel-Palade bodies.

Authors:  Nikolai I Kiskin; Nicola Hellen; Victor Babich; Lindsay Hewlett; Laura Knipe; Matthew J Hannah; Tom Carter
Journal:  J Cell Sci       Date:  2010-09-01       Impact factor: 5.285

3.  Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926.

Authors:  C J Edgell; J E Haizlip; C R Bagnell; J P Packenham; P Harrison; B Wilbourn; V J Madden
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

4.  Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells.

Authors:  Chun Zhou; Hairu Chen; Fengmin Lu; Hassan Sellak; Jonathan A Daigle; Mikhail F Alexeyev; Yaguang Xi; Jingfang Ju; Jan A van Mourik; Songwei Wu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-12-15       Impact factor: 5.464

5.  Structural organization of Weibel-Palade bodies revealed by cryo-EM of vitrified endothelial cells.

Authors:  John A Berriman; Sam Li; Lindsay J Hewlett; Sebastian Wasilewski; Fedir N Kiskin; Tom Carter; Matthew J Hannah; Peter B Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-29       Impact factor: 11.205

6.  Divergent fates of P- and E-selectins after their expression on the plasma membrane.

Authors:  M Subramaniam; J A Koedam; D D Wagner
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

7.  Epigenetically coordinated GATA2 binding is necessary for endothelium-specific endomucin expression.

Authors:  Yasuharu Kanki; Takahide Kohro; Shuying Jiang; Shuichi Tsutsumi; Imari Mimura; Jun-Ichi Suehiro; Youichiro Wada; Yoshihiro Ohta; Sigeo Ihara; Hiroko Iwanari; Makoto Naito; Takao Hamakubo; Hiroyuki Aburatani; Tatsuhiko Kodama; Takashi Minami
Journal:  EMBO J       Date:  2011-06-10       Impact factor: 11.598

8.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

9.  The emergence of the endothelial cell lineage in the chick embryo can be detected by uptake of acetylated low density lipoprotein and the presence of a von Willebrand-like factor.

Authors:  Z Yablonka-Reuveni
Journal:  Dev Biol       Date:  1989-03       Impact factor: 3.582

10.  Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.

Authors:  J Gebrane-Younès; E M Cramer; L Orcel; J P Caen
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.